01 / Contract Profile
75A50124C00052 Federal Contract Award
Agency code 7505
THE PURPOSE OF THIS MODIFICATION IS TO UPDATE ARTICLE B.3 ESTIMATED COST-PLUS FIXED FEE CLINS, ESTABLISH CLINS 3A (OPTION PERIOD 2A) AND CLIN 3B (OPTION PERIOD 2B), EXERCISE OPTION 3A, AND UPDATE SECTION J - LIST OF ATTACHMENTS, ATTACHMENT #1, STATEM
02 / Contract Size and Status
What is the recorded size and timing of this contract?
03 / Spending Trend
75A50124C00052 contract spending by fiscal year
Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.
Latest fiscal year obligations$14.89M
FY 2026Net obligationsComplete recorded range
| Fiscal year | Net obligations | Actions | Change |
|---|---|---|---|
| FY 2024 | $20.60M | 1 | — |
| FY 2025 | $16.99M | 3 | −17.5% |
| FY 2026 | $14.89M | 1 | −12.3% |
04 / Federal Buyer
Which organization manages this contract?
| Department | Contracting agency | Contracting office |
|---|---|---|
| HEALTH AND HUMAN SERVICES, DEPARTMENT OF | ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE | BARDA - ASPR / DAAPPO / BARDA DCMA |
05 / Contractor
Who holds this federal contract?
4J THERAPEUTICS INC
UEI SZCGV7LQJKR4 · CAGE 9DFF0
06 / NAICS Industries
Which industries classify this contract?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $52.48M | 5 | 100.0% |
07 / Products and Services
What products or services were purchased?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| AN13 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | $52.48M | 5 | 100.0% |
08 / Place of Performance
Where is the work recorded?
PALO ALTO, SANTA CLARA, CALIFORNIA, UNITED STATES
ZIP 943042364
09 / Contract Actions
What modifications and obligations were recorded?
| Signed date | Modification | Obligation | Contracting office | NAICS | PSC |
|---|---|---|---|---|---|
| Aug 21, 2026 | P00004 | $14.89M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Sep 17, 2025 | P00003 | $3 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Mar 18, 2025 | P00002 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Jan 17, 2025 | P00001 | $16.99M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Sep 18, 2024 | Base action | $20.60M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
10 / Reading the Contract
How should this award record be interpreted?
Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.
Verify the buyer
Agency and office identify who manages the procurement relationship.
Follow modifications
Each action can change funding, scope, dates, or administrative terms.
Compare the market
Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.